3,4-Dihydro-4-oxo-N-[(1S)-1-phenylethyl]-2-quinazolinepropanamide
CAS: 1445251-22-8
Ref. 3D-VHC25122
5mg | Descontinuado | ||
10mg | Descontinuado | ||
25mg | Descontinuado | ||
50mg | Descontinuado | ||
100mg | Descontinuado | ||
250mg | Descontinuado |
Informação sobre produto
Rifaximin, a non-absorbable antibiotic, is used to treat travelers' diarrhea and the irritable bowel syndrome. It has been shown to inhibit body weight gain in mice with infectious diseases. Rifaximin inhibits colonic microflora by binding to fatty acids and bacterial cell membranes, thereby preventing their growth. It also decreases symptoms of infectious diseases by stimulating antibody response and inhibiting the synthesis of dna. Rifaximin also has a significant interaction with metabolic disorders such as diabetes.